Literature DB >> 15818405

Polycystic kidney disease prevented by transgenic RNA interference.

P Bouillet, M Robati, M Bath, A Strasser.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15818405     DOI： 10.1038/sj.cdd.4401603

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN： 1350-9047            Impact factor:   15.828


× No keyword cloud information.
  19 in total

1.  Anti-apoptotic Mcl-1 is essential for the development and sustained growth of acute myeloid leukemia.

Authors:  Stefan P Glaser; Erinna F Lee; Evelyn Trounson; Philippe Bouillet; Andrew Wei; W Douglas Fairlie; David J Izon; Johannes Zuber; Amy R Rappaport; Marco J Herold; Warren S Alexander; Scott W Lowe; Lorraine Robb; Andreas Strasser
Journal:  Genes Dev       Date:  2012-01-15       Impact factor: 11.361

2.  Loss of PKD1 and loss of Bcl-2 elicit polycystic kidney disease through distinct mechanisms.

Authors:  P Hughes; M Robati; W Lu; J Zhou; A Strasser; P Bouillet
Journal:  Cell Death Differ       Date:  2005-11-11       Impact factor: 15.828

3.  Bim is responsible for the inherent sensitivity of the developing retinal vasculature to hyperoxia.

Authors:  Shoujian Wang; SunYoung Park; Ping Fei; Christine M Sorenson
Journal:  Dev Biol       Date:  2010-11-01       Impact factor: 3.582

4.  Exacerbation of spontaneous autoimmune nephritis following regulatory T cell depletion in B cell lymphoma 2-interacting mediator knock-out mice.

Authors:  Y M Wang; G Y Zhang; Y Wang; M Hu; J J Zhou; A Sawyer; Q Cao; Y Wang; G Zheng; V W S Lee; D C H Harris; S I Alexander
Journal:  Clin Exp Immunol       Date:  2017-02-28       Impact factor: 4.330

5.  BET inhibition represses miR17-92 to drive BIM-initiated apoptosis of normal and transformed hematopoietic cells.

Authors:  Z Xu; P P Sharp; Y Yao; D Segal; C H Ang; S L Khaw; B J Aubrey; J Gong; G L Kelly; M J Herold; A Strasser; A W Roberts; W S Alexander; C J Burns; D C S Huang; S P Glaser
Journal:  Leukemia       Date:  2016-03-08       Impact factor: 11.528

6.  Pro-apoptotic Bim suppresses breast tumor cell metastasis and is a target gene of SNAI2.

Authors:  D Merino; S A Best; M-L Asselin-Labat; F Vaillant; B Pal; R A Dickins; R L Anderson; A Strasser; P Bouillet; G J Lindeman; J E Visvader
Journal:  Oncogene       Date:  2014-09-29       Impact factor: 9.867

7.  The RUNX3 tumor suppressor upregulates Bim in gastric epithelial cells undergoing transforming growth factor beta-induced apoptosis.

Authors:  Takashi Yano; Kosei Ito; Hiroshi Fukamachi; Xin-Zi Chi; Hee-Jun Wee; Ken-ichi Inoue; Hiroshi Ida; Philippe Bouillet; Andreas Strasser; Suk-Chul Bae; Yoshiaki Ito
Journal:  Mol Cell Biol       Date:  2006-06       Impact factor: 4.272

8.  Bim and Bad mediate imatinib-induced killing of Bcr/Abl+ leukemic cells, and resistance due to their loss is overcome by a BH3 mimetic.

Authors:  Junya Kuroda; Hamsa Puthalakath; Mark S Cragg; Priscilla N Kelly; Philippe Bouillet; David C S Huang; Shinya Kimura; Oliver G Ottmann; Brian J Druker; Andreas Villunger; Andrew W Roberts; Andreas Strasser
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-22       Impact factor: 11.205

9.  Treatment of B-RAF mutant human tumor cells with a MEK inhibitor requires Bim and is enhanced by a BH3 mimetic.

Authors:  Mark S Cragg; Elisa S Jansen; Michele Cook; Claire Harris; Andreas Strasser; Clare L Scott
Journal:  J Clin Invest       Date:  2008-10-23       Impact factor: 14.808

10.  Microarray-based approach identifies microRNAs and their target functional patterns in polycystic kidney disease.

Authors:  Priyanka Pandey; Benedikt Brors; Prashant K Srivastava; Andrea Bott; Susanne N E Boehn; Herrmann-Josef Groene; Norbert Gretz
Journal:  BMC Genomics       Date:  2008-12-23       Impact factor: 3.969
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.